Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Ownership
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
MESOBLAST LTD (MESO)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
10/02/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
Final Director’s Interest Notice, Michael Spooner
",
"
Final Director’s Interest Notice, Michael Spooner
"
07/31/2023
6-K
Quarterly results
07/31/2023
F-6EF
Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
07/31/2023
6-K
Quarterly results
07/11/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
ABN 68 109 431 870 1.3
",
"
Appendix 3H of Mesoblast Ltd
",
"
Appendix 3Y of Mesoblast Ltd
",
"
Appendix 3Y of Mesoblast Ltd
"
06/13/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
Appendix 3Y of Mesoblast Ltd
",
"
Appendix 3Y of Mesoblast Ltd
"
05/26/2023
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/26/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
MESOBLAST REPORTS OPERATIONAL AND FINANCIAL HIGHLIGHTS FOR QUARTER ENDED MARCH 31, 2023
",
"
Investor presentation of Mesoblast Ltd
"
05/18/2023
F-3
Form F-3 - Registration statement by foreign private issuers:
05/10/2023
SC 13G
George Gregory reports a 7.4% stake in Mesoblast Limited
05/03/2023
6-K
Quarterly results
04/04/2023
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/04/2023
EFFECT
Form EFFECT - Notice of Effectiveness:
03/24/2023
F-3
Form F-3 - Registration statement by foreign private issuers:
03/22/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
FDA SCHEDULES PRE-LICENSE INSPECTION OF REMESTEMCEL-L MANUFACTURING
"
02/21/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
REMESTEMCEL-L CLINICAL AND POTENCY STUDIES PRESENTED AT PREMIER MEETING OF TRANSPLANTATION RESEARCH AND THERAPY
"
02/01/2023
6-K
Quarterly results
01/20/2023
SC 13G/A
M&G INVESTMENT MANAGEMENT LTD reports a 12% stake in Mesoblast Limited
01/03/2023
EFFECT
Form EFFECT - Notice of Effectiveness:
12/30/2022
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/28/2022
6-K
Quarterly results
12/27/2022
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/20/2022
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022
F-3
Form F-3 - Registration statement by foreign private issuers:
12/20/2022
POS AM
Form POS AM - Post-Effective amendments for registration statement:
12/07/2022
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
Appendix 3G of Mesoblast Ltd
",
"
Appendix 3H of Mesoblast Ltd
",
"
Appendix 3Y of Mesoblast Ltd
"
11/28/2022
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
CHILDREN TREATED WITH REMESTEMCEL-L SHOW LONG-TERM SURVIVAL THROUGH FOUR YEARS IN STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
",
"
MESOBLAST REPORTS FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS FOR THE PERIOD ENDED SEPTEMBER 30, 2022
",
"
Presentation to Annual General Meeting
",
"
Chairman’s Annual General Meeting address
",
"
Results of Annual General Meeting
"
11/28/2022
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
11/16/2022
6-K
Quarterly results
11/07/2022
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
Corporate Governance Statement and Appendix 4G of Mesoblast Ltd
",
"
Notice of Annual General Meeting of Mesoblast Ltd
",
"
Appendix 4C of Mesoblast Ltd
"
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy